Parallel Bio
Parallel Bio is a biotech company focused on human-first drug discovery. They are developing a platform that combines organoids with AI and robotics to replicate the human immune system, aiming to improve drug development success rates by using true-to-life human models. Their platform helps predict drug success and identify disease targets.
Funding Round: Series A
Funding Amount: $21M
Date: 12-Jun-2025
Investors: AIX Ventures, Amplo, Marc Benioff, Metaplanet, Humba Ventures, Atypical Ventures, Undeterred Capital, Jeff Dean
Markets: Biotech
HQ: Cambridge, Massachusetts, United States
Founded: 2021
Website: https://www.parallel.bio/
LinkedIn: https://www.linkedin.com/company/parallelbio
Crunchbase: https://www.crunchbase.com/organization/parallel-bio
Leave a Comment
Comments
No comments yet.